ReviewThe European respiratory journal2017
An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
Review in The European respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Challenges in translating GINA asthma recommendations into practice: a qualitative study of healthcare professionals in Jordan.BMJ open · 2026Article
- Asthma clinical decision support systems in primary care: an updated scoping review of implementation.NPJ primary care respiratory medicine · 2026Article
- Impact of asthma control on quality of life among palestinian children.Scientific reports · 2025Article
- Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management.Patient preference and adherence · 2023Review
- Asthma Action Plans: An International Review Focused on the Pediatric Population.Frontiers in pediatrics · 2022Article
- A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors.Journal of asthma and allergy · 2022Article
- Essential Role of Pharmacists in Asthma Care and Management.Journal of pharmacy practice · 2021Review
- New Concepts and Technological Resources in Patient Education and Asthma Self-Management.Clinical reviews in allergy & immunology · 2020Review
- A system uptake analysis and GUIDES checklist evaluation of the Electronic Asthma Management System: A point-of-care computerized clinical decision support system.Journal of the American Medical Informatics Association : JAMIA · 2020Article
- Quadrupling inhaled corticosteroid doses.Canadian family physician Medecin de famille canadien · 2019Article
- The Electronic Asthma Management System (eAMS) improves primary care asthma management.The European respiratory journal · 2019Article
- Asthma and Allergy Mobile Apps in 2018.Current allergy and asthma reports · 2019Review
- Review
- New evidence-based tool to guide the creation of asthma action plans for adults.Canadian family physician Medecin de famille canadien · 2019Review
- Solving the mystery of the yellow zone of the asthma action plan.NPJ primary care respiratory medicine · 2018Review
- Improving Asthma Action Plan Completion Rates across Five Divisions in an Academic Children's Hospital.Pediatric quality & safetyArticle
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma action plans (AAPs) reduce healthcare utilisation, improve quality of life and are recommended across guidelines. However, fewer than 25% of patients receive an AAP, partly due to prescribers' inability to complete "yellow zone" instructions (how to intensify therapy for acute loss of control). We sought to review best evidence to develop a practical, evidence-based tool to facilitate yellow zone guidance in adults.We reviewed recent asthma guidelines and adult studies addressing acute loss of asthma control (January 2010 to March 2016). We developed evidence-based rules for yellow zone therapy and operational guidelines to maximise adherence and minimise errors.We reviewed three guidelines and 11 manuscripts (2486 abstracts screened). Recommendations were comparable but some areas lacked guidance. For 15/43 asthma regimens, the commonly recommended four- to five-fold yellow zone inhaled corticosteroid dose increase was problematic due to regulatory dose limits. We identified evidence-based alternatives for 8/15 regimens. Operational guidance included increasing to a maximum of four inhalations while maintaining baseline inhaler frequency and device in the yellow zone.We developed a practical implementation tool to facilitate AAP delivery at the point of care, addressing existing gaps and uncertainties. Our tool should be implemented as part of a multifaceted approach to augment AAP usage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.